Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of CXA-10 in PAH
NCT04053543Phase 2Terminated
- Sponsor
- Complexa Therapeutics
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of 10-nitro-oleic acid in pulmonary arterial hypertension (PAH), sponsored by Complexa Therapeutics. Started Aug 2019; status: terminated.
02
Drugs
10-nitro-oleic acid
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT04053543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04053543.